Figure 1 (Af83fd80 323e 45c6 9ec0 Df1845293bed 01)
Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 71205-022
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 71205-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Af83fd80 323e 45c6 9ec0 Df1845293bed 02)
71205-022-30 (Af83fd80 323e 45c6 9ec0 Df1845293bed 05)
The text describes the packaging of Lisinopril HCTZ tablets containing 20mg/12.5mg of Lisinopril and Hydrochlorothiazide respectively. The package includes 30 yellow, round tablets with "LL" debossed on one side and "B02" on the other side. The product is manufactured and packed by Proficent Rx LP, based in Thousand Oaks, California. The package includes Lot #00000 with an expiry date of 00/00/00. It also mentions important details such as storage conditions and precautions to be taken regarding children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
